LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
The post LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace